The HIPRA headquarters in Amer hosted a HIPRA University course this June focused on the rabbit haemorrhagic disease type 2 (RHDV2) new variant.

The professionals who attended the course were the winners of a draw that took place at the London Vet Show congress held at the end of 2018 in London, United Kingdom, where HIPRA presented ERAVAC^®, the inactivated vaccine against RHDV2.

This HIPRA University, which is the first that the company performs for pet rabbits, offered attendees an update on the RHDV2 and the tools provided by HIPRA for its diagnosis, control and prevention.

In addition, it had the participation of Ivan Crotaz (member of the Royal College of Veterinary Surgeons) and Jo Hinde (Director of LagoLearn & Junior Vice President of the BVNA) who presented the situation of the disease in the United Kingdom and the perspective from a veterinary clinician.

The course is part of the HIPRA University continuing education program, which offers tailored training solutions for veterinarians. With this action, HIPRA reinforces its commitment to Animal Health Prevention.